GENEVA, July 9 -- TELIOS PHARMA INC. filed a patent application (US2025/061559) for “COMPOSITIONS COMPRISING A BTK INHIBITOR AND METHODS OF TREATING AN INFLAMMATORY DISEASE OR CONDITION”. With publication no. WO/2026/147931, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 31/506
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....